Novel Services Released at Creative Biolabs Streamline Research on Cell and Gene Therapy

Dec 1, 2022

New York City, New York Nov 30, 2022 (Issuewire.com) - Cell and gene therapies, as highly promising treatment modalities, have already shown phenomenal potential in reversing previously incurable and torturous diseases. With a bright future ahead, however, they present newness that adds a great deal of complexity to the development and manufacturing process. With a unique perspective across the landscape of cell and gene therapy, Creative Biolabs draws upon broad experiences to craft tailored solutions and help clients optimize and accelerate novel therapy development.

Now, the team has updated the service package with brand new human leukocyte antigen (HLA) typing services for cell therapy and antisense oligonucleotide (ASO) services for gene therapy.

  • HLA Typing Services

Powered by accumulated HLA expertise as well as several high-resolution sequencing platforms, Creative Biolabs has developed a dedicated NGS-based HLA typing service.

The standard workflow includes sample preparation, HLA PCR, library construction, NGS Seq, raw data, bioinformatics analysis, and high-resolution HLA results, which are just for reference and will be adjusted according to the specific requirements of clients. Creative Biolabs offers the most researched HLA types covering HLA-A, B, C, G, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, and DPB1. Other types are also available and detailed information can be further discussed with the scientific team.

In addition to HLA typing service, Creative Biolabs also extends its expertise to a full spectrum of high-resolution killer-cell immunoglobulin-like receptor (KIR) typing services, including KIR typing at the DNA and mRNA level, as well as KIR phenotyping by FACS.

  • Antisense Oligonucleotide Services

An extensive portfolio of ASO services is also updated recently based on innovative technology platforms and years of experience in gene therapy development. The scientist team offers reliable custom antisense oligonucleotide synthesis in ready-to-use duplex multi-scale quantities, and the ASO produced can be used as structural and mechanistic probes in diverse areas of diagnostic and therapeutic applications.

In addition to customer services, Creative Biolabs also offers a series of ready-to-use ASO products for various disease research, covering cancer, cytomegalovirus retinitis, viral hemorrhagic fever, and HIV/AIDS.

With no standard on study design, study conduct, or regulatory process in this specialized area, Creative Biolabs understands the high stakes for clients' advanced cell or gene therapy programs and prides itself on flexibility and customization. It's easy for clients to adapt custom solutions to their specific projects and a sophisticated manager will lead and de-risk the workflow to make informed decisions and set the right groundwork to succeed.

About Creative Biolabs

Leveraging decades of experience and self-established platforms, Creative Biolabs has developed extensive breadth and depth of therapeutic expertise to assist a diverse range of cell and gene therapy research through the development pipeline. The comprehensive, end-to-end cell and gene therapy CRO solutions cover CAR-T cell therapy, TCR-T cell therapy, and CAR-MA therapy, as well as gene editing, RNAi development, and delivery vehicle development for gene therapy.

Source :Creative Biolabs

This article was originally published by IssueWire. Read the original article here.

More News

Why the PM could finally drop the triple lock pension pledge
Sep 28, 2026
Why the PM could finally drop the triple lock pension pledge

Andy Burnham said that he would make tough decisions to fund a new national care service.

Healey to promise 'new age of industrialisation' for UK in conference speech
Sep 28, 2026
Healey to promise 'new age of industrialisation' for UK in conference speech

The chancellor will unveil policies aimed at boosting British shipbuilding in his speech to Labour's annual conference on Monday.

How much is in your savings account?
Sep 28, 2026
How much is in your savings account?

From £65 to $60,000 - we talk savings with people in East London's Brick Lane.

How waste food helps families through the week
Sep 28, 2026
How waste food helps families through the week

The scheme runs in schools across the West Midlands, including Birmingham and Walsall.

Uni student living at home 'wasn't ready' to move away
Sep 28, 2026
Uni student living at home 'wasn't ready' to move away

A third of students starting courses are living at home, the University of Gloucestershire says.

My hometown shows that high streets have to change or die
Sep 27, 2026
My hometown shows that high streets have to change or die

Aberdeen is launching an ambitious bid to revive its struggling centre. Could it offer lessons for other high streets?

TV Networks to Resume Trump Coverage, Even as White House Excludes CNN
Sep 27, 2026
TV Networks to Resume Trump Coverage, Even as White House Excludes CNN

The White House TV pool went dark this past week amid a standoff between CNN and the president. Network leaders, however, believe an indefinite suspension may be untenable.

International businesses watch for results from Xi-Trump summit
Sep 27, 2026
International businesses watch for results from Xi-Trump summit

International businesses watch for results from Xi-Trump summit

A 7-Day Standoff That Said So Much About Trump and the Media
Sep 27, 2026
A 7-Day Standoff That Said So Much About Trump and the Media

An abrupt decree, a network boycott, a legal intervention and an uneasy détente: This was no typical battle between a president and his press corps.

Women Sluggers Are No Longer in a League of Their Own
Sep 27, 2026
Women Sluggers Are No Longer in a League of Their Own

As a group of players from an all-women’s baseball league in the 1940s and ’50s gathered at a recent reunion, the future of women’s baseball looks bright again.

BizDataDive: China travel made easier
Sep 27, 2026
BizDataDive: China travel made easier

BizDataDive: China travel made easier

As A.I. Accelerates, Governments Are Increasingly Being Left Behind
Sep 27, 2026
As A.I. Accelerates, Governments Are Increasingly Being Left Behind

The gap between technology and policymaking has gotten wider than ever with artificial intelligence, leaving a global policy vacuum as A.I. models rapidly advance.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter